Evidence map›Paper›PMID 30644026›Full record

ArticleInternational ophthalmology2019

Transcultural validation of the 5-Item Dry Eye Questionnaire for the Mexican population.

Jaime D Martinez, Anat Galor, Guillermo Amescua, Nallely Ramos-Betancourt, Francisco Beltrán, Alejandro Babayán Sosa, Concepción Santacruz Valdés, Cecilia Ramírez-Assad, Elsa Mora Juárez, Everardo Hernández-Quintela

Abstract readValidation Study
In one paragraph

Article in International ophthalmology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ocular Surface Disease IndexIndian journal of ophthalmology · 2021
    Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jaime D MartinezCornea and Refractive Surgery Department, Asociación Para Evitar la Ceguera (APEC), Universidad Nacional Autónoma de México, #46 Vicente García Torres, Delegación Coyoacán, 04030, México City, México.
Anat GalorOphthalmology Department, Miami Veterans Affairs Medical Center, Miami, FL, USA.
Guillermo AmescuaCornea and Ocular Surface Service, Bascom Palmer Eye Institute, University of Miami, Miami, FL, USA.
Nallely Ramos-BetancourtCornea and Refractive Surgery Department, Asociación Para Evitar la Ceguera (APEC), Universidad Nacional Autónoma de México, #46 Vicente García Torres, Delegación Coyoacán, 04030, México City, México.
Francisco BeltránCornea and Refractive Surgery Department, Asociación Para Evitar la Ceguera (APEC), Universidad Nacional Autónoma de México, #46 Vicente García Torres, Delegación Coyoacán, 04030, México City, México.
Alejandro Babayán SosaCornea and Refractive Surgery Department, Fundación Hospital "Nuestra Señora de la Luz" IAP, México City, México.
Concepción Santacruz ValdésCornea and Refractive Surgery Department, Instituto de Oftalmología Fundación Conde de Valenciana, México City, México.
Cecilia Ramírez-AssadRheumatology and Systemic Vasculitis, Hospital Christus Muguerza Saltillo, Coahuila, México.
Elsa Mora JuárezPsychology Department, Asociación Para Evitar la Ceguera (APEC), México City, México.
Everardo Hernández-QuintelaCornea and Refractive Surgery Department, Asociación Para Evitar la Ceguera (APEC), Universidad Nacional Autónoma de México, #46 Vicente García Torres, Delegación Coyoacán, 04030, México City, México. evehq@yahoo.com.ORCID http://orcid.org/0000-0002-5734-4168

Funding

Shared Equipment ModuleP30EY014801 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Victor L Perez · 2004 to 2026
$12.2M
Dry Eye and MicroenvironmentR01EY026174 · NEI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALOR, ANAT, KUMAR, NARESH · 2016 to 2020
$1.9M
NEI NIH HHS P30 EY014801NEI NIH HHS R01 EY026174
6 · The paper itself

Abstract

purposeTo translate and validate a Spanish-language adaptation of the 5-Item Dry Eye Questionnaire for the Mexican population.

methodsBased on the MAPI Institute guidelines, the linguistic validation procedures consisted of four steps. Every step was reviewed by the committee. The translated validated questionnaire was applied to 25 Mexican subjects. The questionnaires were completed by the same subjects at three time points, 8 h apart on the same day and then 3 days later. Sensitivity and specificity of the DEQ-5 to predict DE signs was subsequently estimated in 200 patients see in the Asociación para Evitar la Ceguera ophthalmology clinic.

resultsDuring the forward translation step analysis, the committee decided to change the severity scale, as the words "constantly" and "frequently" are synonymous in Spanish, so it was modified by changing "constantly" to "always" for better understanding. Overall, the intra-test intra-class correlation coefficient from tests administered on the same day was 0.9 (95% CI 0.77-0.95, p = 0.0005). The intra-test intra-class correlation coefficient from tests administered 3 days apart was 0.9 (95% CI 0.88-0.97, p = 0.0005). When applying the questionnaire to 200 patients seen in an eye clinic, we found a sensitivity of 76% and a specificity of 31% for a DEQ-5 score of ≥ 6, against 2 or more positive signs of dry eye.

conclusionMAPI methodology proved to be a reliable strategy for the transcultural Dry Eye Questionnaire for translation from English to Spanish for the Mexican population.

Indexed as

Cross-Cultural ComparisonAdolescentAdultAgedAged, 80 and overDiagnostic Techniques, OphthalmologicalDry Eye SyndromesFemaleHumansMaleMexicoMiddle AgedPsychometricsReproducibility of ResultsSensitivity and SpecificitySurveys and QuestionnairesDry eye diseaseDry eye questionnaireOcular surface disease

Identifiers

PMID30644026
PMCPMC13471042

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.